MYNZ
Mainz Biomed N.V. · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website mainzbiomed.com
- Employees(FY) 58
- ISIN NL0015000LC2
Performance
+3.17%
1W
-28.69%
1M
-32.68%
3M
-40.88%
6M
-41.39%
YTD
-87.24%
1Y
Profile
Mainz Biomed N.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics. It offers ColoAlert, a colorectal cancer screening stool-based deoxyribonucleic acid test; and PancAlert, a product candidate for a pancreatic cancer screening test. The company has a research collaboration with Microba Life Sciences to discover and develop novel therapeutics for major diseases. The company was founded in 2008 and is based in Mainz, Germany.
Technical Analysis of MYNZ 2024-05-10
Overview:
In analyzing the technical indicators for MYNZ stock over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible future stock price movement. By examining these key indicators, we aim to offer valuable insights and recommendations for potential inves...
Recent News & Updates
- 2023-11-19 19:01
- 2023-11-15 19:01
- 2023-11-14 20:01
- 2023-11-12 20:00
- 2023-11-08 19:01
- 2023-11-06 19:01
- 2023-10-31 20:40
Why Is Mainz Biomed (MYNZ) Stock Moving Today?(Investorplace)
- 2023-10-30 20:01
- 2023-10-25 20:01
- 2023-10-17 20:01
- 2023-10-17 03:16
- 2023-10-10 20:01
- 2023-10-10 03:53
Big Pharma Could Transform Into BioTech Pharma(Yahoo Finance)
- 2023-10-04 20:01
- 2023-10-04 02:10
- 2023-10-03 20:01
- 2023-09-27 01:43
- 2023-09-26 20:01
- 2023-09-22 02:51
AI To Revolutionize Clinical Trials And Diagnostics(Yahoo Finance)
- 2023-09-19 15:01
- 2023-09-13 02:31
- 2023-09-12 15:01
- 2023-09-05 02:06
- 2023-09-04 15:01
- 2023-08-28 15:01
- 2023-08-21 15:01
- 2023-08-14 15:01
- 2023-07-31 15:01
- 2023-07-17 15:01
- 2023-06-28 15:01
Mainz Biomed Secures up to $50M in New Funding(Yahoo Finance)